If you love someone who uses cocaine or methamphetamine — or you’re living it yourself — you may have noticed something confusing. For opioids and alcohol, there are well-known medications: methadone, buprenorphine, naltrexone. But when you go looking for the equivalent “detox pill” for stimulants, you come up empty. That gap is real, and it leaves a lot of people feeling like there’s no help available. There is. Stimulant use disorder is highly treatable; it just gets better through a different door than opioid or alcohol addiction does. This guide explains why, and what actually works.

Why Stimulants Don’t Have an FDA-Approved Medication

Cocaine and methamphetamine act on the brain’s dopamine system differently than opioids or alcohol act on theirs. Opioids bind to specific receptors that a medication can safely occupy or block, which is what makes medication-assisted treatment so effective for opioid use disorder. Stimulants instead flood the brain with dopamine and norepinephrine and disrupt the reward circuitry more diffusely, so there is no single receptor to target. Despite decades of research, the National Institute on Drug Abuse notes that no medication has yet been approved specifically to treat cocaine or methamphetamine use disorder (NIDA: Stimulants). That doesn’t mean medication never has a role — prescribers sometimes use medications off-label or to manage co-occurring conditions — but the backbone of recovery from stimulants is behavioral, not pharmacological.

What Stimulant Withdrawal Actually Looks Like

People are often surprised that stimulant withdrawal is not physically dangerous the way alcohol or benzodiazepine withdrawal can be. There are usually no seizures and no medical emergency from stopping. Instead, the “crash” is overwhelmingly psychological: profound fatigue, heavy sleep, a flattened ability to feel pleasure, increased appetite, vivid dreams, and — most dangerously — deep depression and intense cravings that can last for weeks. This is exactly when relapse and, in some cases, suicidal thinking are most likely. A supervised setting matters here, not to manage blood pressure but to keep a person safe and supported through the emotional low. Our medical detox program in Los Angeles provides that monitored, stabilizing first step before the real work of recovery begins.

The Treatments With the Strongest Evidence

Because medication isn’t the answer for stimulants, the field has spent years identifying which therapies genuinely move the needle. A few stand out. Contingency management — a structured approach that provides tangible rewards for verified periods of abstinence — has some of the strongest research support of any stimulant intervention. Cognitive behavioral therapy helps people identify the thoughts and situations that drive use and build concrete skills to interrupt that chain. The Matrix Model, developed specifically for stimulant users, combines education, relapse-prevention skills, family involvement, and regular drug testing over several months. Motivational interviewing helps resolve the ambivalence that so often keeps people stuck. These approaches work best when they’re delivered together and given enough time, which is why structured addiction treatment tends to outperform going it alone.

Cocaine and Meth Aren’t the Same Problem

It’s worth naming that these two stimulants behave differently, and treatment reflects that. Cocaine produces a shorter, more intense high and a fast cycle of bingeing and crashing, which can drive compulsive use over a single night. Methamphetamine stays in the body far longer, can fuel days-long binges without sleep, and is associated with more pronounced cognitive effects and, in some people, stimulant-induced psychosis that needs careful clinical management. We tailor care accordingly through dedicated cocaine rehab and methamphetamine rehab tracks, rather than treating every stimulant the same way.

Treating What’s Underneath the Use

Stimulant use rarely exists in a vacuum. Many people are using to manage untreated depression, anxiety, ADHD, trauma, or the exhaustion of trying to keep up with demanding lives. When those underlying conditions go unaddressed, the odds of lasting recovery drop sharply. That’s why integrated dual diagnosis treatment — treating the substance use and the mental health condition at the same time, by the same team — is so important. Heavy stimulant use can also mimic or unmask psychiatric symptoms, so an accurate assessment over time, rather than a snapshot during early withdrawal, gives a person the clearest path forward.

Why the Right Level of Care Matters

Recovery from stimulants asks a lot of the brain’s reward system, and that system needs time to heal. For many people, the protected structure of residential treatment — away from the cues, people, and places tied to use — gives early recovery the best possible chance. Others continue with structured aftercare and ongoing therapy as stability grows. The honest truth supported by research is that longer engagement predicts better outcomes; brief, one-time interventions rarely hold against the strong cravings stimulants leave behind. Recovery is absolutely possible, and the people who reach it are not the ones with the most willpower — they’re the ones who got the right support and stayed connected to it.

You Don’t Have to Figure This Out Alone

If cocaine or meth has taken more from you or someone you love than it gives back, that’s reason enough to reach out — you don’t have to wait for a rock bottom. To talk through options confidentially, call our admissions team at 855-778-8668 or reach out online. If you or someone nearby is in immediate crisis or having thoughts of suicide, call or text the 988 Suicide & Crisis Lifeline right away. Help is available, and the first conversation is often the hardest part.

What the Evidence Base Tells Us About Stimulant Use Disorder Treatment

Unlike opioid use disorder, stimulant use disorder has no FDA-approved medication. Treatment is built on evidence-based behavioral interventions. The American Society of Addiction Medicine’s National Practice Guideline for stimulant use disorder identifies contingency management — structured positive reinforcement for verified abstinence — as the single intervention with the most consistent evidence of effectiveness. Cognitive behavioral therapy and the community reinforcement approach are also strongly supported.

The Centers for Disease Control and Prevention’s overdose data show that overdose deaths involving stimulants — particularly methamphetamine and cocaine — have risen sharply in recent years, with much of that rise driven by the increasing presence of synthetic opioids like fentanyl in the stimulant drug supply. This contamination changes the clinical picture: someone who believes they are using only cocaine or methamphetamine may unknowingly be exposed to a potent opioid, with the risk of overdose that comes with it.

Why Residential Care Often Matters More for Stimulants

The acute withdrawal from stimulants is rarely medically dangerous in the way alcohol or benzodiazepine withdrawal can be, but the psychological and cognitive features — severe anhedonia, depressive symptoms, sleep disruption, and intense cravings — often peak in the first two to three weeks. Residential treatment during this window provides the structure and clinical attention that early stimulant recovery requires, while the brain’s reward system begins to recalibrate. This article is informational only and is not a substitute for individualized clinical evaluation.